Sharepoint Solutions
PRODUCTS
-
In today’s competitive and capital-constrained cell and gene therapy environment, early decisions around Chemistry, Manufacturing, and Controls (CMC) can make or break a therapy's timeline, cost-efficiency, and eventual approval. Yet many emerging cell therapy companies struggle with CMC strategy until it becomes a bottleneck.
-
Our integrated technology platforms can enable an unprecedented breadth of advanced therapies, including gene therapies, autologous and allogeneic cell therapies, and induced pluripotent stem cells (iPSCs)-derived regenerative therapies.
-
Get faster process insights and dynamic control of substrate feeding without the loss of bioreactor or fermenter volume.
Keep Your Cells Happy
Fluctuations in glucose levels, associated with infrequent measurements and bolus feeding, may cause metabolic deregulation and undesirable process deviations.
That’s where MAVEN comes in. It has your back, automatically monitoring and controlling glucose and lactate concentrations, helping you realize your PAT strategy.
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
Optimized performance and fast bioreactor setup
Single-use bioreactors provide higher throughput thanks to easy setup and operation. Plus minimal operator handling reduces the ever-present risk of contamination. The Applikon AppliFlex ST has been designed to make your life in the lab easy.
WHITE PAPERS AND CASE STUDIES
-
The Impact Of Artificial Intelligence On CQV
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Topliss Sets In Drug Design Technical Notes For The Medicinal Chemist
When considering new, innovative, and efficient drug design processes, you may want to review Professor J G Topliss's non-mathematical operational schemes for analogue design.
-
3 Ways To Address Sterility Assurance Requirements Of The EU GMP Annex 1
Learn about the three key proactive steps companies need to take to meet the sterility assurance requirements of the EU GMP Annex 1 for the manufacture of sterile medicinal products.
-
How To Run Successful Clinical Trials In Japan
Read about why there is no longer any excuse not to include Japan as an integral part of any global clinical-development program for either pharmaceuticals or medical devices.
-
Streamline Recruitment With Confidence
Transform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.
-
Research Site Network Enhances Study Startup With Reliable ICF Writing Services
With help from a new informed consent form (ICF) writing partner, discover how CenExel Clinical Research was able to streamline processes and launch new studies faster.
-
Top Therapeutic Areas In The Asia Pacific Clinical Trial Landscape
Explore why the Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions as trial locations
-
Inspecting On The Edge — Understanding Punch Tip Wear
Why is a horizontal optical comparator highly recommended for tablet manufacturers as a measuring tool for punch tip inspection, and what strategies can be used to detect, reduce, and prevent tip wear?
-
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study
Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
Process Scale Column Packing Instructions
Explore a comprehensive guide to using DurA Cycle A50, a high-capacity, alkaline stable protein A affinity chromatography resin for the downstream processing of mAbs and recombinant proteins.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Accelerating Rare Disease Trials With Biometrics Services
Find out how one therapeutics company regained control over its data assets while increasing its ability to conduct comprehensive oversight and review activities across all data sources for faster decision-making and analysis time.
NEWS
-
EPA Announces $268M WIFIA Loan For Substantial Water Reuse Project In Virginia10/24/2024
Today, the U.S. Environmental Protection Agency announced a $268M Water Infrastructure Finance and Innovation Act (WIFIA) loan to Hampton Roads Sanitation District (HRSD), which serves areas across southeast Virginia and the Eastern Shore.
-
Safeguarding Citrus: International Collaboration Between Australia And Indonesia, Targets Huánglóngbìng Threat6/25/2025
NSW Department of Primary Industries and Regional Development (NSW DPIRD) has reaffirmed its commitment to protecting Australia’s citrus industry through international collaboration against huánglóngbìng (HLB), also known as citrus greening disease.
-
New Study Highlights Rewilding's Role In Tackling Flood And Drought Challenges2/26/2024
Rewilding is the large-scale restoration of ecosystems to the point where nature is allowed to take care of itself.
-
Biden-Harris Administration Announces $3B For Lead Pipe Replacement To Advance Safe Drinking Water As Part Of Investing In America Agenda5/2/2024
Today, May 2, the U.S. Environmental Protection Agency announced $3B from President Biden’s Investing in America agenda to help every state and territory identify and replace lead service lines, preventing exposure to lead in drinking water.
-
Klarna Announces Partnership With OnePay To Exclusively Power Installment Loans At Walmart In The U.S3/17/2025
Klarna, the AI-powered payments and commerce network, today announced that it will be partnering with OnePay, a leading consumer finance app, to exclusively offer installment loans for purchases at Walmart in the United States.